Meticulous Research® Unveils Groundbreaking Report on Global High Throughput Screening Market

 

Meticulous Research®, a leading global market research company, today announced the release of its comprehensive report, titled, High Throughput Screening Market by Technology (Cell-Based Assays [2D, 3D], Label-Free, Lab-on-Chip), Offering (Reagents, Liquid Handling, Readers, Sample Prep), Application (Target Identification, Toxicology, Stem Cell), End User - Global Forecast to 2031. The report offers an in-depth analysis of the high throughput screening (HTS) market, which is projected to achieve a value of $47.41 billion by 2031, growing at a compound annual growth rate (CAGR) of 10.1% from 2024 to 2031.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3206

Market Overview

The global HTS market is driven by several key factors, including the increasing adoption of advanced technologies by pharmaceutical and biotechnology companies, heightened funding for drug discovery, a growing number of drug targets, and the rising number of HTS facilities. However, challenges such as high capital investment requirements and evolving regulatory landscapes are tempering market growth.

The report highlights the promising opportunities presented by the burgeoning biotechnology sectors in countries like Singapore and India, as well as technological innovations within HTS. Conversely, complexities in data handling and potential for false positives remain significant hurdles for market expansion.

Emerging Trends

Key trends shaping the HTS landscape include:

  • Multiplexed HTS Assays: Enhancing screening efficiency.
  • Miniaturization of HTS Assays: Reducing costs and improving throughput.
  • AI Integration: Leveraging artificial intelligence for more accurate results.
  • Ultra-High-Throughput Screening (uHTS): Accelerating drug discovery.
  • Organ-on-Chip Technologies: Providing more relevant in vivo data.

Key Players

The report identifies leading players in the HTS market, including:

  • Thermo Fisher Scientific, Inc. (U.S.)
  • Agilent Technologies, Inc. (U.S.)
  • Merck KGaA (Germany)
  • Danaher Corporation (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Revvity Inc. (U.S.)
  • Tecan Group Ltd. (Switzerland)
  • Axxam S.p.A. (Italy)
  • Charles River Laboratories International, Inc. (U.S.)
  • Hamilton Company (U.S.)
  • Promega Corporation (U.S.)
  • Aurora Biomed Inc. (Canada)

Market Segmentation and Forecast

By Technology: In 2024, cell-based assays are expected to dominate the market, with 3D cell culture showing the highest CAGR due to its superior mimicry of organ microarchitecture.

By Offering: The consumables and reagents segment is anticipated to hold the largest market share, driven by advancements in kit development and the wide availability of HTS reagents.

By Application: Target identification is projected to be the leading application area in 2024, supported by increasing investments in drug discovery and the adoption of automated HTS systems.

By End User: The pharmaceutical and biotechnology sectors are expected to represent the largest share of the HTS market in 2024, driven by rising R&D investments and funding for new drug development.

Geographic Insights

The report provides a detailed regional analysis, with the Asia-Pacific region, particularly China, poised to register the highest CAGR. This growth is attributed to increased pharmaceutical R&D spending and a rising number of drug discoveries. For example, BeiGene Ltd., a prominent Chinese pharmaceutical company, reported a 12.4% increase in R&D spending in 2022. Additionally, China’s NMPA saw a record number of IND and NDA applications in early 2022, underscoring the country's expanding role in global drug development.

Quick Buy @ https://www.meticulousresearch.com/Checkout/82641893

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Comments

Post a Comment

Popular posts from this blog

E-bikes Market to be Worth $88.3 Billion by 2030—Exclusive Report by Meticulous Research®”

   “E-bikes Market to be Worth $88.3 Billion by 2030—Exclusive Report by Meticulous Research®” According to a new market research report titled, ‘ E-bikes Market by Propulsion Type (Throttle-assisted and Dual Mode), Class, Power Output, E-bike Type, Battery Type, Motor Type (Hub Motors and Mid-drive Motors), Structure, Charging Type, Charging Mode, and End User — Global Forecast to 2030, the ‘e-bikes market is projected to reach $88.3 billion by 2030, at a CAGR of 11.9% during the forecast period . Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5555    E-bikes are bicycles with a battery-powered assist that comes via pedaling and, in some cases, a throttle. In e-bikes, the motor will get its power from a rechargeable battery mounted on the bike. E-bikes are a flexible, eco-friendly, and versa...
Read more

U.S. Ambulatory EHR Market to be Worth $3.57 Billion by 2030

  Meticulous Research ® —a leading market research company, published a research report titled,  ‘ U.S. Ambulatory EHR Market  by Delivery Mode (Cloud-based, On-premise), Type, Practice Size (Large, Small-to-medium, Solo), Application (Patient Portals, Practice Management, CDS, Computerized Physician Order Entry, PHM), and End User - Forecast to 2030.’ Download Sample Report Here @   https://www.meticulousresearch.com/download-sample-report/cp_id=5609 According to this latest publication from Meticulous Research ® , the ambulatory EHR market in the U.S. is projected to reach $3.57 billion by 2030, at a CAGR of 5.2% from 2023 to 2030. Increasing government support for the adoption of EHR solutions, patients’ increasing preference for ambulatory care over in-patient care, and the growing need to reduce operating costs in the healthcare industry are the key factors driving the U.S. ambulatory EHR market. Additionally, the integration of artificial intelligence ...
Read more

Wi-Fi 6 Market Worth $105.4 Billion by 2028

   “Wi-Fi 6 Market Worth $105.4 Billion by 2028” Meticulous Research®—a leading global market research company, published a research report titled " Wi-Fi 6 Market  by Devices (Mesh Routers, Access Points, Home Gateways, Repeaters), Commercial Use (Enterprises, Consumers), Application (Consumer Electronics, Healthcare, Manufacturing, Smart Cities, AR/VR, Others), and Geography — Global Forecasts to 2028" . Download Free Sample Report Here :  https://www.meticulousresearch.com/download-sample-report/cp_id=5238 The Wi-Fi 6 market is expected to grow at a CAGR of 73.8% by value from 2021 to reach $105.4 billion by 2028. The increasing demand for high-speed internet connection, growing number of internet users and devices, and rising adoption of Wi-Fi 6 Devices for smart home applications are some of the key factors driving the growth of the Wi-Fi 6 mar...
Read more